Physician profile
Collin Mckenzie
NPI 1598298481
$5,646.33
in general payments reported to CMS, 2019-2025
9 companies · $3,928 in 2025
The $3,928 reported for 2025 was more than what 90% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $39.13 · 2023: $877 · 2024: $802 · 2025: $3,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,088 · Travel and Lodging: $2,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,087.67 |
| Travel and Lodging | $2,519.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,660.27 | 2023-2025 | General - Therapies, General - Female Sui, Solyx Sis System |
| Medtronic, INC. | $1,160.43 | 2023-2025 | Interstim |
| Biotissue Holdings INC. | $504.19 | 2025 | |
| Axonics, INC. | $131.39 | 2024 | Bulkamid |
| Kite Pharma, INC. | $82.55 | 2023 | Yescarta |
| Abbvie INC. | $35.10 | 2025 | |
| Sumitomo Pharma America, INC. | $33.27 | 2025 | Gemtesa |
| Coloplast Corp | $24.12 | 2022 | |
| Hologic Sales and Service, LLC | $15.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.